
    <html>
    <head><title>WEED.TO</title>
<style>
body {
  font-family: Arial, sans-serif;
  margin: 20px;
}
.container {
  display: grid;
  grid-template-columns: 50% 50%;
  grid-template-rows: auto auto;
  gap: 20px;
}
img {
  width: 100%;
  height: auto;
  max-height: 400px;
  border: 1px solid #ccc;
  object-fit: contain;
}

.cell {
  padding: 10px;
}
.table-scroll {
  max-height: 400px;
  overflow-y: auto;
  border: 1px solid #aaa;
}
table {
  width: 100%;
  border-collapse: collapse;
}
th, td {
  border: 1px solid #aaa;
  padding: 5px;
  text-align: left;
  font-size: 14px;
}
.negative {
  background: linear-gradient(to right, #ffdddd, white);
}
.positive {
  background: linear-gradient(to right, white, #ddffdd);
}
.pos-light  { background: #e6ffe6; }  
.pos-mid    { background: #99ff99; }  
.pos-strong { background: #33cc33; }   

.neg-light  { background: #ffe6e6; }   
.neg-mid    { background: #ff9999; }   
.neg-strong { background: #ff3333; }   

h2 { border-bottom: 2px solid #444; }
<script>
function toggleText(id) {
  const moreText = document.getElementById(id);
  const btn = document.getElementById(id + "_btn");

  if (moreText.style.display === "none") {
    moreText.style.display = "inline";
    btn.innerText = " Show less";
  } else {
    moreText.style.display = "none";
    btn.innerText = " Show more";
  }
}
</script>
</style>
</head>
    <body>
    <h2><span style='color:#1e66f5; font-weight:900; margin-right:10px;'>quarterly results d</span> WEED.TO  
        <span style='font-weight:normal; font-size: 18px;'>(14d - annual results)</span>
        <span style='color:black; font-weight:bold; font-size: 20px;'> </span>
        <a href='https://finance.yahoo.com/chart/WEED.TO?interval=1mo' target='_blank'>Yahoo</a>
        <span style='font-weight:600;'>  â€” </span>
    </h2>

    <div class="container">
        <div class="cell"><p><i>No image</i></p></div>
        <div class="cell"><p><i>No image</i></p></div>
        <div class="cell"><p><i>No image</i></p></div>
        <div class="cell"><div class='table-scroll'><table><tr><th>Date</th><th>Score</th><th>AMR</th><th>Type</th><th>Summary</th><th>Links</th></tr><tr class='pos-light'><td>2025-09-09</td><td>0.20</td><td></td><td>Product launch</td><td>0.2 local feel              __   WEED.TO __    -> i:0.2<-                      <br><br>FEELING: total score 0.2 Reasoning: The news primarily revolves around a new product launch (VEAZY vaporizer) by STORZ & BICKEL, a subsidiary of WEED.TO (Canopy Growth). Here's the breakdown: Product Launches (+0.2): The launch of a new product with strong market potential generally receives a positive score. The description highlights accessibility and broader consumer reach, suggesting potential for increased market share. The price point ($249) and features (compact, portable, Bluetooth connectivity) are presented as positive attributes. Subsidiary Relationship (0): The fact that STORZ & BICKEL is a subsidiary of Canopy Growth is informational but doesn't inherently impact the stock value unless it implies a significant financial contribution or strategic shift. Future Sales and Reception (0): The call for investors to "monitor initial sales and consumer reception" is a forward-looking statement, but it's not a definitive positive or negative signal yet. It's a condition to be observed. Other details: The technical specifications and availability details are largely irrelevant to a stock value assessment. The overall impact is mildly positive due to the potential for increased market share and broader consumer reach, but the actual impact will depend on the product's success in the market. --- <br> - STORZ & BICKEL's new VEAZY vaporizer expands their reach with a more accessible and stylish device at $249. This move, backed by Canopy Growth, could boost market share and introduce the brand to a broader consumer base. Investors should monitor initial sales and consumer reception. <br><br>*** REZUMAT *** - New product: VEAZY vaporizer launched by STORZ & BICKEL. - Subsidiary of: STORZ & BICKEL is a subsidiary of Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC). - Launch date: September 9, 2025. - Price point: $249 USD, making it more accessible. - Key feature: Compact and portable (0.3lbs). - Color options: Four colors - Pink, Orange, Blue, and Black. - Heating: Patented mini heater (conduction & convection). - Heat-up time: ~40 seconds. - Bluetooth: Connects to STORZ & BICKEL web app. - Charging: USB-C, 80% charge in 40 minutes. - Availability: Online and in select retailers in over 100 countries.   (gemma3:12b-it-q4_K_M on 2025-09-10 00:39:21)</td><td><a href='https://markets.ft.com/data/announce/detail?dockey=600-202509091200BIZWIRE_USPRX____20250909_BW162411-1' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-09-08</td><td>0.35</td><td></td><td>Insider buying</td><td>0.35 local feel              __   WEED.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Here's a breakdown of the scoring: Insider Buying (Auxly & Rubicon): +0.2 (Significant insider buying signals confidence and commitment. The amounts are substantial, indicating a positive outlook.) Revenue Growth (Auxly): +0.1 (33% YoY revenue growth is a positive indicator of business performance.) Production Capacity Increase (Rubicon): +0.05 (Increasing production capacity to 15,500 kg by 2026 suggests growth potential.) Revenue Growth (Rubicon): +0.05 (24% YoY revenue growth is a positive indicator of business performance.) Canopy Growth Underperformance: -0.05 (The fact that Canopy Growth is down 37.3% year-to-date is a negative signal, although it's backward-looking.) Low-Scoring Items (Not factored significantly into the total): Canadian Insider Index performance (general market data) P/E ratio comparison (relative valuation) Facility acquisition (Rubicon) - while positive, the impact is limited without more details. Backward-looking revenue comparisons (year-over-year growth) - these are already reflected in the current performance. --- <br> - Canadian cannabis stocks present opportunities, particularly Auxly and Rubicon, supported by recent insider buying and positive financial performance. Monitor Canopy Growth for potential future insider activity, but currently prioritize the companies demonstrating commitment and growth. <br><br>*** REZUMAT *** - INK Canadian Insider Index up 16.4% in first eight months of 2025. - Auxly Cannabis (XLY-T) ranks high on valuations, insider commitment, and price momentum. - Auxly's P/E ratio is 9.2, below the Canadian average of 17.8. - CEO Hugo Alves bought $250,000+ of Auxly shares, 440,000 at $0.17 on Aug. 19. - Conrad Tate (Auxly director) bought 485,000 shares at $0.17 on Aug. 19. - Auxly's Q2 revenue was $38.8 million, up 33% year-over-year. - Rubicon Organics (ROMJ-X) up 37.5% year-to-date. - Rubicon acquired a 47,500 sq ft facility for $4.5 million on June 5. - Rubicon's production capacity will increase to 15,500 kg by 2026. - Director Karen Proud bought 34,000 Rubicon shares at $0.44. - Rubicon's Q2 revenue was $15 million, up 24% year-over-year. - Canopy Growth (WEED-T) down 37.3% year-to-date. - No senior officer/director buying in Canopy Growth in 2025.   (gemma3:12b-it-q4_K_M on 2025-09-08 23:00:44)</td><td><a href='https://www.theglobeandmail.com/investing/markets/inside-the-market/article-canada-cannabis-auxly-stocks/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-08-30</td><td>0.20</td><td></td><td>Guidance updates</td><td>0.2 local feel              __   WEED.TO __    -> i:0.2<-                      <br><br>FEELING: total score +0.2 Reasoning: Here's a breakdown of the scoring based on the provided news and the defined events: Anticipated revenue growth: The news highlights an anticipated revenue growth of 7.7% annually for the next three years, exceeding the industry average of 4.8%. This is a positive signal and contributes a score of +0.2. Stock Surge: The 70% surge in stock price this month is a significant event, but it's largely a reaction to the anticipated revenue growth. While positive, it's already factored into the +0.2 score from the revenue growth forecast. High P/S Ratio & Declining Revenue: The high P/S ratio (2.2x) and declining revenue performance (4.2% last year, 41% over three years) are cautionary notes. However, they don't necessarily negate the potential for future growth. They suggest the market is pricing in significant future performance, which is a risk. Backward-Looking Data: The news includes a lot of backward-looking data (last year's decline, three-year decline). This receives a very low score and is largely ignored. Analyst Forecasts: The mention of analyst forecasts supporting the high P/S due to the revenue outlook receives a low score as analyst ratings generally do. --- <br> - Canopy Growth's stock surged 70% this month, driven by optimism surrounding potential revenue growth. However, the high P/S ratio (2.2x) warrants caution and further investigation into the sustainability of future revenue forecasts. <br><br>*** REZUMAT *** - WEED stock jumped 70% this month after a prior decline. - 12-month shareholder losses remain significant at 65%. - P/S ratio is 2.2x, higher than most Canadian pharmaceutical companies. - Recent revenue performance is declining compared to industry averages. - Revenue declined 4.2% last year and 41% over three years. - Anticipated revenue growth: 7.7% annually for the next three years. - Industry revenue growth forecast: 4.8% annually. - Analyst forecasts support the high P/S due to revenue outlook.   (gemma3:12b-it-q4_K_M on 2025-09-04 21:31:15)</td><td><a href='https://simplywall.st/stocks/ca/pharmaceuticals-biotech/tsx-weed/canopy-growth-shares/news/revenues-tell-the-story-for-canopy-growth-corporation-tsewee' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-08-27</td><td>0.30</td><td></td><td>quarterly results</td><td>0.3 local feel              __   WEED.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Assessment: The news highlights that Dollarama exceeded sales expectations, driven by strong consumer demand. This falls under the category of quarterly or annual results being above expectations. This warrants a score of +0.2 to +0.4. I'm leaning towards the lower end of that range (+0.3) because while positive, it's a single data point (sales) and doesn't necessarily guarantee sustained future growth. The commentary about "potential future growth" is forward-looking but not concrete enough to significantly boost the score. --- <br> - Dollarama exceeded sales expectations, indicating strong consumer demand. Investors may find this a positive signal for the company's performance and potential future growth. <br><br>*** REZUMAT *** - Dollarama reported quarterly sales exceeding estimates. - Strong consumer demand drove the positive sales results. - News pertains to sales performance and consumer trends.   (gemma3:12b-it-q4_K_M on 2025-08-28 01:58:14)</td><td><a href='https://ca.finance.yahoo.com/news/dollarama-beats-quarterly-sales-estimates-111546599.html' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-08-26</td><td>0.30</td><td></td><td>Regulatory changes</td><td>0.3 local feel              __   WEED.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Reasoning: The primary driver of the news is "optimism surrounding potential cannabis rescheduling." This falls under regulatory changes, which, if beneficial to the industry (which rescheduling potentially would be), warrants a score of +0.2. The significant price increase (15.7%) reinforces the positive sentiment, adding a slight boost. The mention of monitoring future performance indicates a forward-looking perspective. The Yahoo branding/data usage news is irrelevant to the financial outlook and receives a negligible score. --- <br> - Canopy Growth (CGC) experienced a significant price increase due to optimism surrounding potential cannabis rescheduling. Investors should monitor regulatory developments and their impact on the company's future performance. <br><br>*** REZUMAT *** - CGC stock rose 15.7% on rescheduling optimism. - News related to Yahoo's branding and data usage. - Potential regulatory changes impacting cannabis sector.   (gemma3:12b-it-q4_K_M on 2025-08-27 01:12:37)</td><td><a href='https://finance.yahoo.com/news/canopy-cgc-goes-15-7-162102668.html' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-08-26</td><td>0.30</td><td></td><td>merger announcement</td><td>0.30 GPT4 / 0.45 local feel              __   WEED.TO __    -> i:0.3<-                      <br><br>FEELING: 0.3 --- <br> - Cannabis stocks saw significant gains last week, fueled by the SAFE Banking Act's progress and positive company announcements. Investors should monitor the SAFE Banking Act's Senate approval and company-specific developments for continued potential. <br><br>*** REZUMAT *** - MJ ETF rose over 30% last week on SAFE Banking Act news. - CGC increased +3.02%, signed U.S. distribution agreement. - APHA rose +10.73%, CEO confident in Tilray merger & U.S. legalization. - SNDL increased +4.51%, committed $188M to SunStream Bancorp. - HEXO rose +13.53%, filed a base shelf prospectus for flexibility. - OGI increased +11.41%, launched two new Edison dried flower strains.   <br> <br>-- GPT4: +0.3, Hold, SAFE Banking Act progress boosts sentiment; watch for Senate approval.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-08-27 01:15:55)</td><td><a href='https://www.thestreet.com/investing/cannabis-stocks-watchlist-hexo-aphria-organigram-marijuana-stocks-surge' target='_blank'>Link</a></td></tr><tr class='neg-light'><td>2025-08-15</td><td>-0.20</td><td></td><td>lawsuit</td><td>-0.2 local feel              __   WEED.TO __    -> i:0.2<-                      <br><br>FEELING: total score -0.2 Reasoning: The news primarily revolves around a lawsuit from Louisiana concerning child protection. This falls under the category of "lawsuits." Significant litigation or government investigation typically warrants a negative score. Given the potential for future legal costs and impact on investor sentiment, a score of -0.2 is appropriate. The Yahoo cookie information and user privacy settings are irrelevant to the financial outlook of WEED.TO. --- <br> - Roblox faces a lawsuit from Louisiana regarding child protection, potentially impacting investor sentiment and future legal costs. Monitor developments closely. <br><br>*** REZUMAT *** - Louisiana sues Roblox. - Allegation: Failure to protect children. - Yahoo uses cookies for analytics and advertising. - Users can manage privacy settings. - Potential legal costs for Roblox.   (gemma3:12b-it-q4_K_M on 2025-08-16 02:38:59)</td><td><a href='https://ca.finance.yahoo.com/news/louisiana-sues-roblox-alleging-popular-231517808.html' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-08-15</td><td>0.30</td><td></td><td>Regulatory change</td><td>event_TBD 0.30 GPT4 / 0.35 local feel              __   WEED.TO __    -> i:0.3<-                      <br><br>FEELING: 0.3 --- <br> - Canopy Growth is well-positioned to benefit from the potential rescheduling of cannabis to Schedule III in the U.S., which could unlock tax savings, facilitate U.S. market entry, and attract investors. While the stock faces short-term volatility, the long-term outlook appears positive. <br><br>*** REZUMAT *** - U.S. government considering rescheduling cannabis from Schedule I to Schedule III. - This move would recognize medical benefits, ease research, and offer tax relief for cannabis businesses. - Canopy Growth holds U.S. cannabis assets via Canopy USA (Acreage, Wana Brands, Jetty). - Canadian adult-use cannabis revenue increased 43% year-over-year in Q1 FY2026 (C$27 million). - Total cannabis revenue up 24%, consolidated net revenue up 9% (C$72.1 million). - Company achieved CA$17 million of CA$20 million annualized cost savings target. - Potential rescheduling could unlock tax savings and accelerate U.S. market entry. - WEED stock opened at C$2.08 (TSX), CGC at US$1.52 (NASDAQ), both down ~6%.   <br> <br>-- GPT4: +0.3, Hold, Rescheduling could boost U.S. entry and tax savings, but short-term volatility persists.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-08-16 03:02:14)</td><td><a href='https://stockhouse.com/news/the-market-online-news/2025/08/15/u-s-federal-cannabis-rescheduling-a-game-changer-for-canopy-growth' target='_blank'>Link</a></td></tr><tr class='neg-light'><td>2025-08-15</td><td>-0.20</td><td></td><td>share consolidation proposal</td><td>event_TBD -0.2 local feel              __   WEED.TO __    -> i:0.2<-                      <br><br>FEELING: total score -0.2 Reasoning: Here's a breakdown of the score based on the provided news and the defined events: Share Consolidation: The news explicitly mentions "share consolidation." This typically carries a negative connotation as it's often a measure taken to avoid delisting or signal financial distress. Score: -0.3 Analyst Rating: The stock has a "Sell" rating. This is a negative signal. Score: -0.1 Financial Performance Concerns: The news highlights "financial performance concerns," "declining revenues," and "profitability." This is a significant negative. Score: -0.2 Proxy Meeting/Quorum: The urging of shareholders to vote to ensure a quorum is a minor negative, suggesting potential governance issues or lack of shareholder engagement. Score: -0.05 Neutral/Low Impact Items (not factored into the score): Mailing of proxy materials - standard corporate procedure. Auditor reappointment - routine. TipRanks AI rating (Neutral) - lacks strong directional impact. Market Cap - purely descriptive. The negative factors outweigh the neutral ones, resulting in a slightly negative overall score. --- <br> - Canopy Growth urges shareholders to vote at the upcoming meeting to ensure a quorum and avoid extra costs. Despite some positive technical signals, the stock faces headwinds due to financial performance concerns and a "Sell" rating. <br><br>*** REZUMAT *** - Canopy Growth mailed proxy materials for the 2025 shareholder meeting. - Shareholder voting is crucial for quorum and to avoid additional costs. - Resolutions include director election, auditor reappointment, and share consolidation. - Analyst rating: Sell with a C$1.50 price target. - TipRanks AI rates the stock as Neutral. - Financial performance is weak, with declining revenues and profitability. - Market Cap: C$468.9M.   (gemma3:12b-it-q4_K_M on 2025-08-16 03:06:30)</td><td><a href='https://www.tipranks.com/news/company-announcements/canopy-growth-urges-shareholders-to-vote-in-upcoming-meeting' target='_blank'>Link</a></td></tr></table></div></div>
    </div>
    </body>
    </html>
    